The Leadership Team at Trishula Therapeutics is responsible for driving the strategic vision and operational execution of the company’s clinical programs, particularly the development of TTX-030. This team, comprising experts in immunology, translational sciences, and manufacturing chemistry, leads key decision-making processes, fostering collaboration across departments to advance innovative cancer immunotherapy solutions. Their collective expertise ensures alignment on research and development goals while navigating the complexities of clinical trials and regulatory compliance.
View all